Cussenot O - Search Results

1

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, Kraft P, Wacholder S, Orr N, Berndt S, Yu K, Hutchinson A, Wang Z, Amundadottir L, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Haiman CA, Henderson B, Kolonel L, Le Marchand L, Siddiq A, Riboli E, Key TJ, Kaaks R, Isaacs W, Isaacs S, Wiley KE, Gronberg H, Wiklund F, Stattin P, Xu J, Zheng SL, Sun J, Vatten LJ, Hveem K, Kumle M, Tucker M, Gerhard DS, Hoover RN, Fraumeni JF Jr, Hunter DJ, Thomas G, Chanock SJ. Yeager M, et al. Among authors: cussenot o. Nat Genet. 2009 Oct;41(10):1055-7. doi: 10.1038/ng.444. Epub 2009 Sep 20. Nat Genet. 2009. PMID: 19767755 Free PMC article.

2

Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.

Cormier L, Valéri A, Azzouzi R, Fournier G, Cussenot O, Berthon P, Guillemin F, Mangin P. Cormier L, et al. Among authors: cussenot o. Prostate. 2002 Jun 1;51(4):276-85. doi: 10.1002/pros.10092. Prostate. 2002. PMID: 11987156

3

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.

Valeri A, Cormier L, Moineau MP, Cancel-Tassin G, Azzouzi R, Doucet L, Baschet F, Cussenot I, L'Her J, Berthon P, Mangin P, Cussenot O, Morin JF, Fournier G. Valeri A, et al. Among authors: cussenot o, cussenot i. J Urol. 2002 Aug;168(2):483-7. doi: 10.1016/s0022-5347(05)64663-0. J Urol. 2002. PMID: 12131293

4

Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.

Azzouzi AR, Valeri A, Cormier L, Fournier G, Mangin P, Cussenot O. Azzouzi AR, et al. Among authors: cussenot o. Urology. 2003 Jun;61(6):1193-7. doi: 10.1016/s0090-4295(03)00033-5. Urology. 2003. PMID: 12809896

5

Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.

Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, Berthon P, Cussenot O. Cancel-Tassin G, et al. Among authors: cussenot o. Eur Urol. 2003 Oct;44(4):487-90. doi: 10.1016/s0302-2838(03)00319-1. Eur Urol. 2003. PMID: 14499686

6

[Genetic susceptibility to prostate cancer].

Cussenot O, Cancel-Tassin G. Cussenot O, et al. Med Sci (Paris). 2004 May;20(5):562-8. doi: 10.1051/medsci/2004205562. Med Sci (Paris). 2004. PMID: 15190476 Free article. Review. French.

7

[Hereditary forms of kidney cancer and genetic screening].

Valeri A, Cussenot O. Valeri A, et al. Among authors: cussenot o. Prog Urol. 2003 Nov;13(5 Suppl 2):1201-4. Prog Urol. 2003. PMID: 15816384 Review. French. No abstract available.

8

Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.

Fromont G, Valeri A, Cher M, Pontes JE, Vallancien G, Validire P, Latil A, Cussenot O. Fromont G, et al. Among authors: cussenot o. Prostate. 2005 Dec 1;65(4):341-6. doi: 10.1002/pros.20304. Prostate. 2005. PMID: 16015610

9

Genetic susceptibility to prostate cancer.

Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. Among authors: cussenot o. BJU Int. 2005 Dec;96(9):1380-5. doi: 10.1111/j.1464-410X.2005.05836.x. BJU Int. 2005. PMID: 16287462 Review. No abstract available.

10

Low penetrance genetic susceptibility to kidney cancer.

Thibault F, Cancel-Tassin G, Cussenot O. Thibault F, et al. Among authors: cussenot o. BJU Int. 2006 Oct;98(4):735-8. doi: 10.1111/j.1464-410X.2006.06351.x. BJU Int. 2006. PMID: 16978268 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

516 results

Search Page